IAIM
LGND icon

International Assets Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

International Assets Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Buy
88
+84
+2,100% +$19.8K ﹤0.01% 1515
2026
Q1 		$798 Sell
4
-9
-69% -$1.78K ﹤0.01% 2090
2025
Q4 		$2.46K Buy
+13
New +$2.5K ﹤0.01% 1932
2024
Q3 		– Sell
-81
Closed -$6.83K – 2290
2024
Q2 		$6.83K Buy
+81
New +$6.45K ﹤0.01% 1771
2021
Q2 		– Sell
-478
Closed -$30K – 1256
2021
Q1 		$30K Hold
478
– – ﹤0.01% 1136
2020
Q4 		$30K Buy
+478
New +$27.3K 0.01% 1017

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

International Assets Investment Management's LGND Position: Q2 2026 in Review

International Assets Investment Management increased its Ligand Pharmaceuticals (LGND) stake by 2,100% in Q2 2026, buying an estimated $19.8K and bringing the position to 88 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

International Assets Investment Management first reported a position in LGND in Q4 2020 and has held it in 6 quarters since. The position peaked at $30K in Q1 2021. 173 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • International Assets Investment Management held 88 shares of Ligand Pharmaceuticals worth $27.5K as of Q2 2026.
  • International Assets Investment Management bought 84 Ligand Pharmaceuticals shares in Q2 2026, an estimated $19.8K.
  • Ligand Pharmaceuticals made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1515 holding.
  • International Assets Investment Management first reported a position in Ligand Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
  • International Assets Investment Management's Ligand Pharmaceuticals position peaked at $30K in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.